Exelixis (EXEL) Insider Trading & Ownership $44.04 -0.33 (-0.73%) As of 10:55 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Exelixis (NASDAQ:EXEL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.82%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$8.74 MNumber OfInsiders Selling(Last 12 Months)11Amount OfInsider Selling(Last 12 Months)$43.27 M Get EXEL Insider Trade Alerts Want to know when executives and insiders are buying or selling Exelixis stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address EXEL Insider Buying and Selling by Quarter Exelixis Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/16/2025Amy C PetersonCMOSell72,776$45.47$3,309,124.72 5/16/2025Christopher J SennerCFOSell100,000$46.00$4,600,000.00 5/16/2025George PosteDirectorSell20,634$45.99$948,957.66 5/15/2025Jeffrey HessekielEVPSell25,000$46.18$1,154,500.00 5/15/2025Patrick J HaleyEVPSell126,383$47.96$6,061,328.68 5/15/2025Stelios PapadopoulosDirectorSell36,508$44.35$1,619,129.80 5/14/2025Patrick J HaleyEVPSell10,000$42.68$426,800.00 5/1/2025Dana AftabEVPSell1,508$39.00$58,812.00 3/3/2025Patrick J HaleyEVPSell10,000$38.80$388,000.00 2/28/2025Jack L WyszomierskiDirectorSell8,768$37.80$331,430.40 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 2/28/2025Jack L WyszomierskiDirectorSell8,768$37.80$331,430.40 2/25/2025Bob OliverDirectorSell18,647$37.25$694,600.75 2/24/2025Christopher J SennerCFOSell29,314$36.14$1,059,407.96 2/24/2025Patrick J HaleyEVPSell52,636$36.98$1,946,479.28 2/14/2025Mary C BeckerleDirectorSell12,210$34.88$425,884.80 11/29/2024Jeffrey HessekielEVPSell60,000$36.67$2,200,200.00 11/22/2024Patrick J HaleyEVPSell10,000$35.27$352,700.00 11/18/2024Patrick J HaleyEVPSell41,588$34.36$1,428,963.68 11/5/2024Dana AftabEVPSell96,986$35.00$3,394,510.00 11/1/2024George PosteDirectorSell30,000$34.00$1,020,000.00 11/1/2024Jeffrey HessekielEVPSell50,000$34.13$1,706,500.00 10/30/2024Dana AftabEVPSell1,162$31.40$36,486.80 10/28/2024Jeffrey HessekielEVPSell25,000$28.39$709,750.00 9/23/2024Jeffrey HessekielEVPSell25,000$26.38$659,500.00 8/26/2024Jeffrey HessekielEVPSell20,000$25.79$515,800.00 8/14/2024Maria C FreireDirectorSell8,250$26.56$219,120.00 8/12/2024Dana AftabEVPSell20,883$27.06$565,093.98 8/9/2024Christopher J SennerCFOSell125,000$27.19$3,398,750.00 8/8/2024George PosteDirectorSell33,725$26.89$906,865.25 8/7/2024Dana AftabEVPSell95,000$25.00$2,375,000.00 6/4/2024Jack L WyszomierskiDirectorSell8,287$22.00$182,314.00 5/30/2024David Edward JohnsonDirectorBuy225,000$20.76$4,671,000.00 5/28/2024David Edward JohnsonDirectorBuy200,000$20.32$4,064,000.00 5/21/2024George PosteDirectorSell11,686$20.96$244,938.56 (Data available from 1/1/2013 forward) EXEL Insider Trading Activity - Frequently Asked Questions Who is on Exelixis's Insider Roster? The list of insiders at Exelixis includes Alan M Garber, Amy C Peterson, Bob Oliver, Carl B Feldbaum, Christopher J Senner, Dana Aftab, David Edward Johnson, George Poste, Jack L Wyszomierski, Jeffrey Hessekiel, Maria C Freire, Mary C Beckerle, Patrick J Haley, Peter Lamb, and Stelios Papadopoulos. Learn more on insiders at EXEL. What percentage of Exelixis stock is owned by insiders? 2.82% of Exelixis stock is owned by insiders. Learn more on EXEL's insider holdings. Which Exelixis insiders have been buying company stock? The following insider purchased EXEL shares in the last 24 months: David Edward Johnson ($15,270,038.49). How much insider buying is happening at Exelixis? Insiders have purchased a total of 735,409 EXEL shares in the last 24 months for a total of $15,270,038.49 bought. Which Exelixis insiders have been selling company stock? The following insiders have sold EXEL shares in the last 24 months: Alan M Garber ($461,112.05), Amy C Peterson ($3,309,124.72), Bob Oliver ($694,600.75), Christopher J Senner ($10,288,757.96), Dana Aftab ($6,533,264.78), George Poste ($3,120,761.47), Jack L Wyszomierski ($1,078,599.31), Jeffrey Hessekiel ($9,141,587.30), Maria C Freire ($219,120.00), Mary C Beckerle ($425,884.80), Patrick J Haley ($13,730,233.65), and Stelios Papadopoulos ($1,619,129.80). How much insider selling is happening at Exelixis? Insiders have sold a total of 1,537,879 Exelixis shares in the last 24 months for a total of $50,622,176.59 sold. Exelixis Key ExecutivesDr. Stelios Papadopoulos Ph.D. (Age 76)Co-Founder & Chair of the Board Compensation: $118.25kDr. Michael M. Morrissey Ph.D. (Age 63)CEO, President & Director Compensation: $2.16MMr. Christopher J. Senner (Age 56)Executive VP & CFO Compensation: $1.06M2 recent tradesDr. Dana T. Aftab Ph.D. (Age 60)Executive VP of Discovery and Translational Research & Chief Scientific Officer Compensation: $883.03kMr. Jeffrey J. Hessekiel J.D. (Age 55)Executive VP, General Counsel & Secretary Compensation: $933.08k2 recent tradesDr. Amy C. Peterson M.D. (Age 57)Executive VP, Product Development & Medical Affairs and Chief Medical Officer Compensation: $568.85kMs. Susan T. HubbardExecutive Vice President of Public Affairs & Investor RelationsMs. Laura DillardExecutive Vice President of Human ResourcesDr. Anne Champsaur M.D.Senior Vice President of Drug SafetyDr. William Berg M.D.Senior Vice President of Medical Affairs More Insider Trading Tools from MarketBeat Related Companies Alnylam Pharmaceuticals Insider Trades Biogen Insider Trades United Therapeutics Insider Trades Neurocrine Biosciences Insider Trades Incyte Insider Trades BioMarin Pharmaceutical Insider Trades Exact Sciences Insider Trades Halozyme Therapeutics Insider Trades Repligen Insider Trades Madrigal Pharmaceuticals Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?Sprouts Stock: Insider Sales, But Strong Bullish Signals5 Hot Small-Cap Insiders Bought at the Peak of Tariff FearsThe Top-Ranked Insider Buys From April by Market CapMcDonald’s Insiders Sell Shares! Investors Should Do the Opposite This page (NASDAQ:EXEL) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exelixis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exelixis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
